DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.62 Billion USD | 24.49% |
| 2022 | 2.9 Billion USD | 18.84% |
| 2021 | 2.44 Billion USD | 27.08% |
| 2020 | 1.92 Billion USD | 30.54% |
| 2019 | 1.47 Billion USD | 43.08% |
| 2018 | 1.03 Billion USD | 43.58% |
| 2017 | 718.5 Million USD | 25.33% |
| 2016 | 573.3 Million USD | 42.61% |
| 2015 | 402 Million USD | 55.09% |
| 2014 | 259.2 Million USD | 62.0% |
| 2013 | 160 Million USD | 60.16% |
| 2012 | 99.9 Million USD | 30.99% |
| 2011 | 76.26 Million USD | 56.83% |
| 2010 | 48.63 Million USD | 63.78% |
| 2009 | 29.69 Million USD | 201.82% |
| 2008 | 9.83 Million USD | 112.62% |
| 2007 | 4.62 Million USD | 113.25% |
| 2006 | 2.16 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1 Billion USD | 9.04% |
| 2024 Q3 | 994.2 Million USD | -1.01% |
| 2024 Q1 | 921 Million USD | -10.97% |
| 2023 Q4 | 1.03 Billion USD | 6.1% |
| 2023 Q1 | 741.5 Million USD | -9.04% |
| 2023 Q2 | 871.3 Million USD | 17.51% |
| 2023 Q3 | 975 Million USD | 11.9% |
| 2023 FY | 3.62 Billion USD | 24.49% |
| 2022 Q4 | 815.2 Million USD | 5.93% |
| 2022 FY | 2.9 Billion USD | 18.84% |
| 2022 Q1 | 628.8 Million USD | -9.94% |
| 2022 Q2 | 696.2 Million USD | 10.72% |
| 2022 Q3 | 769.6 Million USD | 10.54% |
| 2021 Q2 | 595.1 Million USD | 17.84% |
| 2021 Q3 | 650.2 Million USD | 9.26% |
| 2021 Q1 | 505 Million USD | -11.23% |
| 2021 FY | 2.44 Billion USD | 27.08% |
| 2021 Q4 | 698.2 Million USD | 7.38% |
| 2020 Q4 | 568.9 Million USD | 13.58% |
| 2020 Q1 | 405.1 Million USD | -12.47% |
| 2020 Q3 | 500.9 Million USD | 10.87% |
| 2020 FY | 1.92 Billion USD | 30.54% |
| 2020 Q2 | 451.8 Million USD | 11.53% |
| 2019 Q2 | 336.4 Million USD | 19.93% |
| 2019 FY | 1.47 Billion USD | 43.08% |
| 2019 Q4 | 462.8 Million USD | 16.78% |
| 2019 Q1 | 280.5 Million USD | -17.01% |
| 2019 Q3 | 396.3 Million USD | 17.81% |
| 2018 FY | 1.03 Billion USD | 43.58% |
| 2018 Q1 | 184.4 Million USD | -16.56% |
| 2018 Q2 | 242.5 Million USD | 31.51% |
| 2018 Q3 | 266.7 Million USD | 9.98% |
| 2018 Q4 | 338 Million USD | 26.73% |
| 2017 Q2 | 170.6 Million USD | 19.89% |
| 2017 Q3 | 184.6 Million USD | 8.21% |
| 2017 FY | 718.5 Million USD | 25.33% |
| 2017 Q4 | 221 Million USD | 19.72% |
| 2017 Q1 | 142.3 Million USD | -16.88% |
| 2016 Q3 | 148.6 Million USD | 8.23% |
| 2016 Q2 | 137.3 Million USD | 18.16% |
| 2016 Q4 | 171.2 Million USD | 15.21% |
| 2016 FY | 573.3 Million USD | 42.61% |
| 2016 Q1 | 116.2 Million USD | -11.16% |
| 2015 FY | 402 Million USD | 55.09% |
| 2015 Q4 | 130.8 Million USD | 24.33% |
| 2015 Q3 | 105.2 Million USD | 12.88% |
| 2015 Q2 | 93.2 Million USD | 28.02% |
| 2015 Q1 | 72.8 Million USD | -13.64% |
| 2014 Q3 | 69 Million USD | 17.35% |
| 2014 Q4 | 84.3 Million USD | 22.17% |
| 2014 FY | 259.2 Million USD | 62.0% |
| 2014 Q1 | 47.1 Million USD | -8.9% |
| 2014 Q2 | 58.8 Million USD | 24.84% |
| 2013 FY | 160 Million USD | 60.16% |
| 2013 Q4 | 51.7 Million USD | 20.51% |
| 2013 Q2 | 35.8 Million USD | 20.95% |
| 2013 Q1 | 29.6 Million USD | -11.02% |
| 2013 Q3 | 42.9 Million USD | 19.83% |
| 2012 Q3 | 23.08 Million USD | -1.54% |
| 2012 Q2 | 23.45 Million USD | 16.7% |
| 2012 Q1 | 20.09 Million USD | -10.37% |
| 2012 FY | 99.9 Million USD | 30.99% |
| 2012 Q4 | 33.26 Million USD | 44.08% |
| 2011 Q4 | 22.42 Million USD | 22.83% |
| 2011 Q3 | 18.25 Million USD | -14.77% |
| 2011 Q2 | 21.41 Million USD | 51.1% |
| 2011 Q1 | 14.17 Million USD | -9.35% |
| 2011 FY | 76.26 Million USD | 56.83% |
| 2010 Q2 | 11.78 Million USD | 23.48% |
| 2010 Q1 | 9.54 Million USD | -8.84% |
| 2010 Q4 | 15.63 Million USD | 34.05% |
| 2010 Q3 | 11.66 Million USD | -1.04% |
| 2010 FY | 48.63 Million USD | 63.78% |
| 2009 Q3 | 7.25 Million USD | 7.52% |
| 2009 FY | 29.69 Million USD | 201.82% |
| 2009 Q4 | 10.47 Million USD | 44.25% |
| 2009 Q2 | 6.75 Million USD | 29.53% |
| 2009 Q1 | 5.21 Million USD | 27.96% |
| 2008 Q4 | 4.07 Million USD | 112.14% |
| 2008 FY | 9.83 Million USD | 112.62% |
| 2008 Q2 | 1.98 Million USD | 6.44% |
| 2008 Q1 | 1.86 Million USD | 21.86% |
| 2008 Q3 | 1.92 Million USD | -3.13% |
| 2007 Q1 | 1.01 Million USD | 21.21% |
| 2007 Q2 | 863 Thousand USD | -14.72% |
| 2007 Q3 | 1.22 Million USD | 41.83% |
| 2007 Q4 | 1.52 Million USD | 24.84% |
| 2007 FY | 4.62 Million USD | 113.25% |
| 2006 Q4 | 834.91 Thousand USD | -0.73% |
| 2006 FY | 2.16 Million USD | 0.0% |
| 2006 Q3 | 841.02 Thousand USD | 75.55% |
| 2006 Q2 | 479.07 Thousand USD | 3142.49% |
| 2006 Q1 | 14.77 Thousand USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -29938.146% |
| BrainsWay Ltd. | 31.78 Million USD | -11296.256% |
| Cerus Corporation | 156.36 Million USD | -2216.537% |
| Envoy Medical, Inc. | 316 Thousand USD | -1146197.468% |
| electroCore, Inc. | 16.03 Million USD | -22497.006% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -562368.944% |
| IceCure Medical Ltd | 3.22 Million USD | -112080.242% |
| Inogen, Inc. | 315.66 Million USD | -1047.532% |
| OrthoPediatrics Corp. | 148.73 Million USD | -2335.454% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -149088.633% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -992313.678% |
| MaxCyte, Inc. | 41.28 Million USD | -8673.251% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -185426.733% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -3270658.84% |
| Orthofix Medical Inc. | 746.64 Million USD | -385.146% |
| PAVmed Inc | 2.45 Million USD | -147628.385% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -15985.528% |
| RxSight, Inc. | 89.07 Million USD | -3966.482% |
| Sight Sciences, Inc. | 81.05 Million USD | -4368.886% |
| SI-BONE, Inc. | 138.88 Million USD | -2508.11% |
| TELA Bio, Inc. | 58.45 Million USD | -6096.945% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -1835.837% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -26146.649% |
| Acutus Medical, Inc. | 7.16 Million USD | -50462.535% |
| Talis Biomedical Corporation | 412 Thousand USD | -879099.029% |
| Spectral AI, Inc. | 18.05 Million USD | -19961.475% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -36470.419% |
| CVRx, Inc. | 39.29 Million USD | -9118.221% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -373831.822% |
| Bioventus Inc. | 512.34 Million USD | -607.004% |
| Venus Concept Inc. | 76.35 Million USD | -4644.087% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -19468.365% |
| LivaNova PLC | 1.15 Billion USD | -214.015% |
| 908 Devices Inc. | 50.22 Million USD | -7111.571% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -651.106% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -4701499.086% |
| NeuroPace, Inc. | 65.42 Million USD | -5436.907% |
| LENSAR, Inc. | 42.16 Million USD | -8490.978% |
| Apyx Medical Corporation | 52.34 Million USD | -6819.521% |
| Cutera, Inc. | 212.36 Million USD | -1605.663% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -10758.865% |
| BioSig Technologies, Inc. | 18 Thousand USD | -20123788.889% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -2073.441% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -15021.269% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | -134.974% |
| Axonics, Inc. | 366.37 Million USD | -888.676% |
| Outset Medical, Inc. | 130.37 Million USD | -2678.349% |
| IRIDEX Corporation | 51.86 Million USD | -6883.555% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -2559.721% |
| IRadimed Corporation | 65.56 Million USD | -5424.974% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -307918.707% |
| INVO Bioscience, Inc. | 3.02 Million USD | -119820.876% |
| Telesis Bio, Inc. | 27.5 Million USD | -13067.691% |
| Viemed Healthcare, Inc. | 183 Million USD | -1879.312% |
| Varex Imaging Corporation | 811 Million USD | -346.646% |
| Quipt Home Medical Corp. | 221.74 Million USD | -1533.565% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -5174.554% |
| Dynatronics Corporation | 32.53 Million USD | -11033.903% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -41641.185% |
| Semler Scientific, Inc. | 68.18 Million USD | -5212.537% |
| InMode Ltd. | 492.04 Million USD | -636.168% |
| Bruker Corporation | 2.96 Billion USD | -22.189% |
| Cytosorbents Corporation | 36.34 Million USD | -9865.232% |
| Align Technology, Inc. | 3.86 Billion USD | 6.213% |
| Viveve Medical, Inc. | 6.42 Million USD | -56269.437% |
| ZimVie Inc. | 457.43 Million USD | -691.876% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -1776.694% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -3270658.84% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | -384.447% |
| Profound Medical Corp. | 7.33 Million USD | -49310.58% |
| Insulet Corporation | 1.69 Billion USD | -113.441% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -2773.063% |
| iCAD, Inc. | 17.31 Million USD | -20816.388% |
| Nuwellis, Inc. | 8.86 Million USD | -40765.298% |
| Biotricity, Inc. | 12.06 Million USD | -29927.327% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -635.222% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -58277.115% |
| PAVmed Inc. | 2.45 Million USD | -147628.385% |
| BIOLASE, Inc. | 49.16 Million USD | -7267.789% |
| Beyond Air, Inc. | 1.15 Million USD | -312436.67% |
| FONAR Corporation | 102.88 Million USD | -3420.758% |
| AxoGen, Inc. | 159.01 Million USD | -2178.004% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -1219.97% |
| Inari Medical, Inc. | 493.63 Million USD | -633.806% |
| UFP Technologies, Inc. | 400.07 Million USD | -805.412% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -19474631.183% |
| Tenon Medical, Inc. | 2.92 Million USD | -123612.432% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -53074.982% |
| AdaptHealth Corp. | 3.2 Billion USD | -13.191% |
| Sintx Technologies, Inc. | 2.62 Million USD | -137787.324% |
| NanoVibronix, Inc. | 2.28 Million USD | -158564.039% |
| Quanterix Corporation | 122.36 Million USD | -2860.169% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -14742.45% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -1706.444% |
| TransMedics Group, Inc. | 241.62 Million USD | -1399.154% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -26046.239% |
| NeuroMetrix, Inc. | 5.9 Million USD | -61280.09% |
| Hyperfine, Inc. | 11.03 Million USD | -32734.482% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -2093.326% |
| Biomerica, Inc. | 5.41 Million USD | -66793.813% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -7064.217% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -1944.949% |